Translate page


Collage VEP Ross White

  Dr David Ross     Dr Deborah White




 Session 3: Future directions for CML

  • TFR trial update 
    (Dr David Ross)
  • Biomarkers and response prediction 
    in CML
    (Dr Deborah White)



David Ross



TFR trial update
Dr David Ross- SA Pathology, Universities of Adelaide and South Australia

  • Deep molecular response and treatment-free remission
  • Imatinib TFR findings
  • TFR experience with nilotinib and dasatinib
  • Maximising eligibility for TFR
  • Future and ongoing research questions
  • Conclusions and practical recommendations


Deborah White


Biomarkers and response prediction in CML
Dr Deborah White - SAHRMI, University of Adelaide

  • Chemokines, cytokines and growth factors
  • KIR genotypes
  • CIP2A
  • Drug transporters
  • Genomics
  • Drug monitoring and compliance